Verrica Pharmaceuticals Announces Positive Topline Results in PhVRCA: Verrica Pharmaceuticals Inc. 2020-11-10 07:30:00 Verrica Pharmaceuticals Announces Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with External Genital Warts (CARE-1)Longby RocketTickersNov 10, 20200
VRCA breaks below 30 RSI, Here we go, get onboard!VRCA Breaks below 30 RSI and has rebounded every time. Momentum is building, get ride it to $12 - $15. NLongby sgtBilk0Jul 28, 20202
VRCA Exit point after RSI dip below 30Once RSI dips below 30 again opening position then dumping at 12.21. NLongby sgtBilk0Jul 23, 20202
VRCA Bounce Back Swing TradeVRCA has been tanking the last few days due to FDA Approval Delays Has a history of bouncing around support and resistance levels around this price Upside is around 80% if positive PR and price action takes place with the weeks Low Float stock, can be volatile. (Enjoy the ride)NLongby OttersOnlyJul 11, 20206